Literature DB >> 6136626

[Effect of histamine H2-receptor antagonists on the hepatic elimination of drugs].

U Klotz, I Reimann.   

Abstract

H2-blocking agents, such as cimetidine or ranitidine are used in numerous patients. This treatment is often associated with the co-administration of a variety of other drugs. From clinical observations and pharmacokinetic studies it is obvious that even short-term treatment with therapeutic doses of cimetidine inhibits the hepatic elimination of antipyrine, warfarin, diazepam, desmethyldiazepam, chlordiazepoxide, propranolol, labetalol, metoprolol, phenytoin, carbamazepine, chlormethiazole, theophylline and caffeine. All these drugs are metabolized by cytochrome-dependent so-called phase I reactions. Cimetidine can interact with drug binding to the cytochrome P450 system leading to impaired drug metabolism. On the other hand drugs which are eliminated by glucuronidation (cytochrome independent phase II reaction), such as oxazepam and lorazepam are not affected by cimetidine. Other H2-blocking agents (ranitidine, oxmetidine) did not impair the elimination of antipyrine, warfarin, diazepam or propranolol. Furthermore, cimetidine and ranitidine might slightly reduce hepatic blood flow which could reduce the elimination of drugs with high hepatic clearance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136626     DOI: 10.1007/bf01487578

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  51 in total

1.  Alterations in the circulatory system of anaesthesized dogs following administration of histamine and histamine H1- and H2-Receptor antagonists in relation to plasma histamine levels.

Authors:  M Thermann; W Lorenz; A Schmal; F Schingale; P Dormann; H Hamelmann
Journal:  Agents Actions       Date:  1975-12

2.  The antipyrine test in clinical pharmacology: conceptions and misconceptions.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

3.  Failure of ranitidine to interact with propranolol.

Authors:  A M Heagerty; C M Castleden; L Patel
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-01

4.  Cimetidine and ranitidine.

Authors:  D Jack; D A Richards
Journal:  Lancet       Date:  1982-04-17       Impact factor: 79.321

5.  Cimetidine and bioavailability of propranolol.

Authors:  M A Donovan; A M Heagerty; L Patel; M Castleden; J E Pohl
Journal:  Lancet       Date:  1981-01-17       Impact factor: 79.321

6.  Delayed clearance of diazepam due to cimetidine.

Authors:  U Klotz; I Reimann
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

7.  Cimetidine interaction with carbamazepine.

Authors:  N Telerman-Toppet; M E Duret; C Cöers
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

8.  Decreased clearance of theophylline due to cimetidine.

Authors:  M M Weinberger; G Smith; G Milavetz; L Hendeles
Journal:  N Engl J Med       Date:  1981-03-12       Impact factor: 91.245

9.  Decreased systemic clearance of caffeine due to cimetidine.

Authors:  L J Broughton; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

10.  Cimetidine spares the glucuronidation of lorazepam and oxazepam.

Authors:  R V Patwardhan; G W Yarborough; P V Desmond; R F Johnson; S Schenker; K V Speeg
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

View more
  6 in total

1.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

Review 2.  The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion.

Authors:  I Walter-Sack
Journal:  Klin Wochenschr       Date:  1987-11-02

3.  Pharmacokinetic and pharmacodynamic interaction study of diazepam and metoprolol.

Authors:  U Klotz; I W Reimann
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.

Authors:  U Klotz; P Arvela; B Rosenkranz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  The inhibition of drug metabolism by cimetidine in patients with liver cirrhosis.

Authors:  R Gugler; M Wolf; H H Hansen; J C Jensen
Journal:  Klin Wochenschr       Date:  1984-12-03

Review 6.  Adverse reactions and interactions with H2-receptor antagonists.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.